About the Grant
To encourage investigative research in histopathology, particularly aimed at generating research data which may contribute towards a substantive application to a funding body.
A maximum sum of £10,000.
Who is eligible?
Trainees (specialist registrars or honorary specialist registrars) consultants & post- doctoral histopathology trainees who are members of the Society.
1 April & 1 October
Please upload completed Part B, Part C documents during the application process.
Please read the full terms and conditions before applying.
Examples of Projects funded from the Trainee Small Grants Scheme
Characterising the DNA methylome in patients with metastatic melanoma treated with immune checkpoint blockade April 2020 Dr R Cooper, University of Oxford
Using IPSC-derived cultures of human intesting for in-vitro modelling of colorectal neoplasia October 2019 Dr W Dalleywater, University of Nottingham
Multi-omic passports of intestinal metaplasia in the human stomach April 2019 Dr O Shutkever, UCL
Immune profiling in Metastatic Uveal Melanoma April 2019 Dr Y Krishna, Univeristy of Liverpool
Is cardiac innervation altered in the inherited cardiomyopathies October 2018 Dr J Westaby St George's University of London
The role of lipocalin2 (LCN2) in breast cancer: A ptential key driver of lymphovascular invcasion April 2018 Dr S Kurozumi, Nottingham City Hosptial
Cancer-associated mutations in normal endometrium April 2018 Dr Luiza Moore, Wellcome Sanger Institute, Cambridge
Elucidating the pathogenesis of mitochodrially inherited tubulointerstitial kidney disease October 2017 Dr James McCaffrey, University of Cambridge
Investigating the Tumour Micrenvieonment using Multiplex Digital Analysis in Non-Caucasian Breast Cancer October 2017 Dr Aisling Longworth, University of Birmingham
Characterising the cancer-associated fibroblast phenotype in lung cancer using single cell RNA sequencing October 2017 Dr Sara Waise, University of Southampton
Investigation of Tumour Infiltrating Lumphocytes as indicators of prognosis and treatment response in Cholangiocarcinoma, October 2017 Dr I Egbuniwe, Queen's Medical Cente, Nottingham
CTCF maintains regulatory homeostasis of cancer pathways Dr S Aitken, University of Cambridge